AGC Biologics Announces Plans for New Manufacturing Site in Yokohama Japan
<h4><i>The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and be operational in 2026</i></h4><p/>SEATTLE, USA - News Direct - 04 January 2024 - <a href="https://www.agcbio.com/"><b>AGC</b> Biologics</a>, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct a new manufacturing facility at AGC Inc.